Long-term treatment with ramipril favourably modifies the haemostatic response to acute submaximal exercise in hypertensives

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 14, Issue 4, 2013, Pages 322-329

  Galea, Vassiliki ^a   Triantafyllidi, Helen ^b   Theodoridis, Theodoros ^a   Koutroumbi, Matina ^b   Christopoulou Cokkinou, Vasiliki ^a   Kremastinos, Dimitrios ^b   Anastasiou Nana, Maria ^b   Lekakis, John ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

acute submaximal exercise; endothelium; Essential hypertension; haemostasis; renin angiotensin aldosterone system antagonists

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIPLASMIN; D DIMER; HYDROCHLOROTHIAZIDE; PADGEM PROTEIN; PROTHROMBIN; PROTHROMBIN FRAGMENT 1+2; RAMIPRIL; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AEROBIC EXERCISE; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; LONG TERM CARE; MALE; OUTCOME ASSESSMENT; THROMBOCYTE FUNCTION; TREATMENT RESPONSE; VASCULAR ENDOTHELIUM;

ACUTE SUBMAXIMAL EXERCISE; ENDOTHELIUM; ESSENTIAL HYPERTENSION; HAEMOSTASIS; RENIN-ANGIOTENSIN ALDOSTERONE SYSTEM ANTAGONISTS;

BLOOD PLATELETS; BLOOD PRESSURE; DEMOGRAPHY; ENDOTHELIUM, VASCULAR; EXERCISE; FIBRIN; FIBRINOLYSIS; HEMOSTASIS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RAMIPRIL; THROMBIN; TIME FACTORS;

EID: 84889822065     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312466125     Document Type: Article

References (46)

1. Lip GYH, Blann AD. Endothelium and fibrinolysis in hypertension. Important facets of a prothrombotic state?. Hypertension. 2008 ; 52: 218-219
2. Felmeden D, Spencer C, Chung N, et al. Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol. 2003 ; 92: 400-405 (Pubitemid 36959875)
3. Chobanian A, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Hypertension. 2003 ; 42: 1206-1252 (Pubitemid 37553153)
4. Guidelines for the management of arterial hypertension. Eur Heart J. 2007 ; 28: 1462-1536
5. Cornelissen V, Fagard R. Effects of endurance training on blood pressure-regulating mechanisms and cardiovascular risk factors. Hypertension. 2005 ; 46: 667-675 (Pubitemid 43186737)
6. Mora S, Cook N, Buring JE, Ridker PM, Lee IM. Physical activity and reduced risk of cardiovascular events. Potential mediating mechanisms. Circulation. 2007 ; 116: 2110-2118 (Pubitemid 350060348)
7. Catena C, Novello M, Lapenna R, et al. New risk factors for atherosclerosis in hypertension: focus on the prothrombotic state and lipoprotein(a). J Hypertens. 2005 ; 23: 1617-1631 (Pubitemid 41233418)
8. Remkova A, Remko M. The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res. 2010 ; 59: 13-23
9. Lekakis J, Triantafyllidi H, Galea V, et al. The immediate effect of aerobic exercise on haemostatic parameters in patients with recently diagnosed mild to moderate essential hypertension. J Thromb Thrombolysis. 2008 ; 25: 179-184 (Pubitemid 351583667)
10. Lottermoser K, Weisser B, Hertfelder HJ, Wöstmann B, Vetter H, Düsing R. Antihypertensive drug treatment and fibirnolytic function. Am J Hypertens. 1998 ; 11: 378-384 (Pubitemid 28186751)
11. Fogari R, Zoppi A. Antihypertensive drugs and fibrinolytic function. Am J Hypertens. 2006 ; 19: 1293-1299
12. Cesari M, Kritchevsky SB, Atkinson HH, et al. Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: Results from the trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. Am Heart J. 2009 ; 157: e1-334
13. Remkova A, Kratochvilova H, Durina J. Impact of the therapy of renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension. J Hum Hypertens. 2008 ; 22: 338-345 (Pubitemid 351566820)
14. Hlubocka Z, Umnerova V, Heller S, et al. Circulating intercellular cell adhesion molecule-1, endothelin-1 and von Willebrand factor-markers of endothelial dysfunction in uncomplicated essential hypertension: the effect of treatment with ACE inhibitors. J Hum Hypertens. 2002 ; 16: 529-531
15. Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991 ; 65: 618-623
16. Muldowney J, Vaughan D. Tissue-type plasminogen activator release. new frontiers in endothelial function. J Am Coll Cardiol. 2002 ; 40: 967-969 (Pubitemid 34994993)
17. Blann AD, de Romeuf C, Mazurier C, McCollum CN. Circulating von Willebrand factor antigen II in atherosclerosis: a comparison with von Willebrand factor and soluble thrombomodulin. Blood Coagul Fibrinolysis. 1998 ; 3: 261-266 (Pubitemid 28255518)
18. Salomaa V, Matei C, Aleksei N, et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in ARIC study: a case cohort study. Lancet. 1999 ; 353: 1729-1734 (Pubitemid 29240370)
19. Spencer CG, Felmeden DC, Blann AD, Lip GY. Effects of "newer" and "older" antihypertensive drugs on hemorrheological, platelet, and endothelial factors. A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Am J Hypertens. 2007 ; 20: 699-704 (Pubitemid 46783995)
20. van Bussel BC, Schouten F, Henry RM, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension. 2011 ; 58: 588-595
21. Gedikli O, Kiris A, Yilmaz H, et al. The relationship between endothelial damage and aortic augmentation index. Clin Exp Hypertens. 2010 ; 32: 29-34
22. du Cailar G, Fesler P, Ribstein J, Mimran A. Dietary sodium, aldosterone, and left ventricular mass changes during long-term inhibition of the renin-angiotensin system. Hypertension. 2010 ; 56: 865-870
23. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on exercise, rehabilitation and prevention) and the Council on Nutrition, Physical Activity, and metabolism (Subcommittee on Physical Activity). Circulation. 2003 ; 107: 3109-3116 (Pubitemid 36758987)
24. Gorog DA. Prognostic value of plasma fibrinolysis activation markers in cardiovascular disease. J Am Coll Cardiol. 2010 ; 55: 2701-2709
25. Levi M, de Boer JP, Roem D, ten Cate JW, Hack CE. Plasminogen activation in vivo upon intravenous infusion of DDAVP. Quantitative assessment of plasmin-alpha 2-antiplasmin complex with a novel monoclonal antibody based radioimmunoassay. Thromb Haemost. 1992 ; 23: 111-116
26. Takahashi H, Tatewaki W, Wada K, Niwano H, Hanano M, Shibata A. Plasmin generation and fibri(ogen)olysis following desmopressin infusion. Am J Hematol. 1991 ; 36: 255-258
27. Stegnar M, Vene N, Bozic M. Do haemostasis activation markers that predict cardiovascular disease exist?. Pathophysiol Haemost Thromb. 2003 ; 33: 302-308 (Pubitemid 40278699)
28. DeSouza CA, Dengel DR, Rogers MA. Fibrinolytic responses to acute physical activity in older hypertensive men. J Appl Physiol. 1997 ; 82: 1765-1770 (Pubitemid 27248928)
29. Smith D, Hoetzer G, Greiner J, Stauffer BL, DeSouza CA. Effects of ageing and regular aerobic exercise on endothelial fibrinolytic capacity in humans. J Physiol. 2003 ; 546: 289-298 (Pubitemid 36104988)
30. Cohen RJ, Epstein SE, Cohen LS, Dennis LH. Alterations in blood fibrinolysis and blood coagulation induced by exercise and the role of beta-adrenergic receptor stimulation. Lancet. 1968 ; II: 1264-1266
31. Van den Burg PJM, Hospers JEH, van Vliet WL, Mosterd WL, Bouma BN, Huisveld IA. Changes in haemostatic factors and activation products after exercise in healthy subjects with different ages. Thromb Haemost. 1995 ; 74: 1457-1464 (Pubitemid 26018073)
32. Claus RA, Bockmeyer CL, Sossdorf M, Lösche W, Hilberg T. Physical stress as a model to study variations in ADAMTS-13 activity, von Willebrand factor level and platelet activation. J Thromb Haemost. 2006 ; 4: 902-905
33. Wang JS. Intense exercise increases shear-induced platelet aggregation in men through enhancement of von Willebrand factor binding, glycoprotein IIb/IIIa activation, and P-selectin expression on platelets. Eur J Appl Physiol. 2004 ; 91: 741-747
34. Wang JS, Liao CH. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men. Thromb Haemost. 2004 ; 91: 587-594
35. O'Sullivan. The effects of exercise training on markers of endothelial function in young healthy men. Int J Sports Med. 2003 ; 24: 404-409 (Pubitemid 37011537)
36. Erikson-Berg M, Egberg N, Eksborg S, Schenck-Gustafsson K. Retained fibrinolytic response and no coagulation activation after acute physical exercise in middle-aged women with previous myocardial infarction. Thromb Res. 2002 ; 105: 481-486 (Pubitemid 34686907)
37. Li-Saw-Hee FL, Blann AD, Edmunds E, Gibbs CR, Lip GY. Effect of acute exercise on the raised plasma fibrinogen, soluble P-selectin and von Willebrand factor levels in chronic atrial fibrillation. Clin Cardiol. 2001 ; 24: 409-414 (Pubitemid 32391203)
38. Gibbs CR, Blann AD, Edmunds E, Watson RD, Lip GY. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm. Clin Cardiol. 2001 ; 24: 724-729 (Pubitemid 33027556)
39. Von Kanel R, Hong S, Pung MA, Mills PJ. Association of blood pressure and fitness with levels of atherosclerotic risk markers pre-exercise and post-exercise. Am Heart J. 2007 ; 20: 67-75
40. Higashi Y, Yoshizumi M. Exercise and endothelial function: Role of endothelium-derived nitric oxide and oxidative stress in healthy subjects and hypertensive patients. Pharmacol Theurapeut. 2004 ; 104: 87-96 (Pubitemid 38429987)
41. Green D, Maiorana A, O'Driscoll, Taylor R. Effects of exercise training on endothelium-derived nitric oxide function in humans. J Physiol. 2004 ; 561: 1-25 (Pubitemid 39549463)
42. Vischer UM. Von Willebrand factor, endothelial dysfunction and cardiovascular disease. J Thromb Haemost. 2006 ; 4: 1186-1193
43. Weiss C, Welsch B, Albert M, et al. Coagulation and thrombomodulin in response to exercise of different type and duration. Med Sci Sports Exerc. 1998 ; 30: 1205-1210 (Pubitemid 28369223)
44. Polgar J, Matuskova J, Wagner DD. The P-selectin, tissue factor, coagulation triad. J Thromb Haemost. 2005 ; 3: 1590-1596 (Pubitemid 41716543)
45. Hilberg T, Gla D, Smidt V, et al. Short-term exercise and platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation. Platelets. 2003 ; 14: 67-74 (Pubitemid 36461462)
46. Ikarugi H, Shibata M, Ishii K, Yamamoto J. Shear-induced platelet reactivity in middle-aged women after low-intensity exercise. Thromb Res. 2001 ; 104: 347-51 (Pubitemid 33152956)